Example: Heart Attack

Search clinical trials for: Neurokinin A

Total 301 results

NCT02820558

Recruiting

Neuropeptide Therapy of Recent Onset Type 1 Diabetes

Conditions: Diabetes Mellitus, Type 1
NCT02036281

Completed

A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain

Conditions: Terminally Ill; Histologically-confirmed Advanced Cancer; Pain, Intractable
NCT01280149

Completed

Reduction of IgE Antibody in Human Allergic Subjects

Conditions: Seasonal Allergic Rhinitis
NCT01599728

Completed

Effect of Urocortins in Patients With Heart Failure

Conditions: Heart Failure; Endothelium
NCT01096693

Suspended

Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2)

Conditions: Vascular Disease; Heart Disease
NCT00547612

Completed

Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer

Conditions: Pancreatic Cancer
NCT01854177

Completed

Differentiating the Effects of Substance P and Beta-endorphin

Conditions: Chronic Obstructive Pulmonary Disease
NCT03836001

Recruiting

A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa

Conditions: Epidermolysis Bullosa
NCT02654483

Completed

Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients

Conditions: Epidermolysis Bullosa; Pruritus
NCT00557700

Completed

Study to Investigate the Effect of Inhaled Tiotropium Bromide on Neurokinin-A Induced Bronchoconstriction in Patients With Mild-to-moderate Asthma

Conditions: Asthma
NCT00735735

Terminated

Measurement of Substance P in Saliva of Low Back Pain Patients

Conditions: Low Back Pain
NCT01625455

Terminated

Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome

Conditions: Sezary Syndrome; Pruritus
NCT04103801

Completed

Substance P as a Biomarker to Evaluate the Reduction of Multiple Immunization Pain

Conditions: Immunisation Anxiety Related Reaction; Pain, Acute
NCT00977223

Completed

Effects of Substance P Antagonists on Adrenal Secretion

Conditions: Healthy Volunteers
NCT01096706

Completed

Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 3)

Conditions: Vascular Disease; Heart Disease
NCT01391598

Unknown status

Lidocaine on Pain Relief and IL and Substance P in Fibromyalgia

Conditions: Fibromyalgia
NCT04468646

Recruiting

To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients

Conditions: Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus
NCT02196324

Completed

A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)

Conditions: Prurigo Nodularis
NCT03035838

Not yet recruiting

Importance of Substance P in Intracranial Pressure Elevation Following Traumatic Brain Injury

Conditions: Traumatic Brain Injury
NCT04594317

Not yet recruiting

Effect of Low-level Laser Therapy Versus Calcium Hydroxide Intracanal Medication on Postoperative Pain and Substance P Levels in Patients With Symptomatic Apical Periodontitis

Conditions: Postoperative Pain; Apical Periodontitis
NCT02357693

Completed

Neurokinin Receptor Antagonist Associated to Ondansetron in PONV

Conditions: Postoperative Nausea and Vomiting
NCT01580423

Completed

The Role of Substance P on Perception of Breathlessness During Resistive Load Breathing

Conditions: Chronic Obstructive Pulmonary Disease
NCT03081897

Unknown status

Regional Anaesthesia and Substance P in Head and Neck Cancer

Conditions: Head and Neck Cancer
NCT03306134

Unknown status

The Effect of Beta-blockers in Substance P Levels and the Swallowing Function

Conditions: Beta Blockers; Swallowing Disorder; Substance P
NCT01458938

Terminated

This Study is to Determine if Degenerative Spinal Pain and Disorders Cause the Levels of Substance P to Change in a Patients Saliva, Blood and/or Cerebrospinal Fluid.

Conditions: Spinal Disease; Spinal Radiculopathy; Myelopathy; Neurogenic Claudication